In recognition of Hidradenitis Suppurativa Awareness week, Thalocan Research Innovations is proud to present our full conversation with Portia Combow, who graciously shares her story about living with HS for nearly twenty years. The generosity of people like Portia not only recognizes all of those who cope with this disease, but serves to inform many…
The third installment in our series, Conversations with Portia Combow: After being incorrectly diagnosed, first with a staph infection and then with folliculitis – Portia discusses her experience and the treatment options she pursued prior to getting correctly diagnosed with Hidradenitis Suppurativa. Watch the full webinar/conversation at www.thalocan.com/webinars/.
“How long did it take to get your diagnosis?” is the next topic in our series, Living with HS – conversations with Portia Combow. As Thalocan continues to work to improve the process of disease assessment in clinical research, we are grateful to Portia as she shares her unique and first-hand experience with Hidradenitis Suppurativa.…
To effectively address challenges in clinical trial endpoint management within the immuno-dermatology therapeutic area, a strong team is essential. We are proud to introduce the talented and driven individuals who make up Thalocan Research Innovations. Their expertise and dedication help our customers capture meaningful data to identify treatments that improve patients’ quality of life.
